Pascal-M Aggensteiner
Biographic Data
| ID | 7961289 |
|---|---|
| NAME | Pascal-M Aggensteiner |
| GIVEN NAMES | Pascal-M |
| FAMILY NAME | Aggensteiner |
| SIGNATURE | AGGENSTEINER P |
| AFFILIATIONS | Heidelberg University |
| ORCID | 0000-0002-1048-9044 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Modification of inhibitory control and craving through transcranial direct current stimulation as an add-on treatment for substance use disorder
Registered at https://clinicaltrials.gov/study/NCT06959342 (Date 26.04.2025)
Lifespan adversities affect neural correlates of behavioral inhibition in adults
Our findings extended previous work and showed that early adverse experiences have a long-term effect on the neural circuitry of inhibitory control in adulthood. Furthermore, the overlap between neural correlates of adversity and depressive symptomatology suggests that adverse experiences might increase vulnerability via neural alterations, which needs to be investigated by future longitudinal research
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD
Current findings indicate a potential value of self-report (BRIEF global score) and some objectively measured neurocognitive indices (CPT commission errors and hit reaction time variability) as treatment markers (of change) for MPH. However, we found a rather limited prognostic value with regard to predicting treatment response not (yet) allowing recommendation for clinical use. Baseline symptom severity was revealed as the most relevant predicto…
No prominent works on this page.
Lifespan adversities affect neural correlates of behavioral inhibition in adults
Our findings extended previous work and showed that early adverse experiences have a long-term effect on the neural circuitry of inhibitory control in adulthood. Furthermore, the overlap between neural correlates of adversity and depressive symptomatology suggests that adverse experiences might increase vulnerability via neural alterations, which needs to be investigated by future longitudinal research
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD
Current findings indicate a potential value of self-report (BRIEF global score) and some objectively measured neurocognitive indices (CPT commission errors and hit reaction time variability) as treatment markers (of change) for MPH. However, we found a rather limited prognostic value with regard to predicting treatment response not (yet) allowing recommendation for clinical use. Baseline symptom severity was revealed as the most relevant predicto…
Modification of inhibitory control and craving through transcranial direct current stimulation as an add-on treatment for substance use disorder
Registered at https://clinicaltrials.gov/study/NCT06959342 (Date 26.04.2025)
Attention Deficit Hyperactivity Disorder (2 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works) · Cognition (2 works) · Neural and Behavioral Psychology Studies (2 works) · Psychology (2 works) · Affect (linguistics (1 work) · Affect regulation (1 work) · Child and Adolescent Psychosocial and Emotional Development (1 work) · Communication (1 work)